| [1] |
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 [J]. European Journal of Cancer, 2013, 49(6): 1374-1403.
|
| [2] |
Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases [J]. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 1997, 15(3): 938-946.
|
| [3] |
Adam R, Hoti E, Folprecht G, et al. Accomplishments in 2008 in the management of curable metastatic colorectal cancer [J]. Gastrointest Cancer Res, 2009, 3(5): S15-22.
|
| [4] |
Adams RB, Aloia TA, Loyer E, et al. Selection for hepatic resection of colorectal liver metastases: expert consensus statement [J]. HPB (Oxford), 2013, 15(2): 91-103.
|
| [5] |
Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection [J]. Hepatol Res, 2009, 39(2): 107-116.
|
| [6] |
Reinhart MB, Huntington CR, Blair LJ, et al. Indocyanine green: historical context, current applications, and future considerations [J]. Surg Innov, 2016, 23(2): 166-175.
|
| [7] |
Schneider PD. Preoperative assessment of liver function [J]. Surg Clin North Am, 2004,84(2):355-373.
|
| [8] |
Wissler EH. Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green [J]. Eur J Appl Physiol, 2011, 111(4): 641-646.
|
| [9] |
Miyagawa S, Makuuchi M, Kawasaki S, et al. Criteria for safe hepatic resection [J]. American journal of surgery, 1995, 169(6): 589-594.
|
| [10] |
Fang CH, Tao HS, Yang J, et al. Impact of three-dimensional reconstruction technique in the operation planning of centrally located hepatocellular carcinoma [J]. J Am Coll Surg, 2015, 220(1): 28-37.
|
| [11] |
Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases [J]. The British Journal of Surgery, 2007, 94(3): 274-286.
|
| [12] |
Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases [J]. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2006, 24(13): 2065-2072.
|
| [13] |
Krieger PM, Tamandl D, Herberger B, et al. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing [J]. Annals of Surgical Oncology, 2011, 18(6): 1644-1650.
|
| [14] |
Narita M, Oussoultzoglou E, Chenard MP, et al. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization [J]. Annals of Surgical Oncology, 2012, 19(7): 2230-2237.
|
| [15] |
Hiwatashi K, Ueno S, Sakoda M, et al. The evaluation of liver function and surgical influence by ICGR15 after chemotherapy for colorectal liver metastases [J]. J Cancer, 2016, 7(5): 595-599.
|
| [16] |
Wakiya T, Kudo D, Toyoki Y, et al. Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis [J]. Annals of surgical oncology, 2014, 21(1): 167-172.
|
| [17] |
Takamoto T, Hashimoto T, Sano K, et al. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis [J]. Annals of Surgical Oncology, 2010, 17(10): 2747-2755.
|
| [18] |
Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy [J]. Annals of surgery, 2008, 247(1): 118-124.
|
| [19] |
Komori H, Beppu T, Baba Y, et al. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients [J]. Int J Clin Oncol, 2010, 15(3): 263-270.
|
| [20] |
Russolillo N, Langella S, Perotti S, et al. Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test [J]. Int J Surg, 2016, 31: 80-85.
|
| [21] |
Klinger M, Eipeldauer S, Hacker S, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases [J]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2009, 35(5): 515-520.
|